Description

Ribavirin Tablets USP (200 mg / 400 mg)

Healthy Inc is a specialized global supplier and exporter of advanced antiviral, hepatology, and critical-care infectious disease therapeutics. We provide ultra-high-purity, kinetically stabilized Ribavirin Film-Coated Tablets (200 mg / 400 mg), manufactured in WHO–GMP certified, high-containment dedicated antiviral facilities. This “Broad-Spectrum Synthetic Nucleoside Analog” is a massive-volume, essential export to hepatology centers, infectious disease NGOs, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally mandated combination therapy for severe Chronic Hepatitis C (HCV) and a strategic stockpile defense against Viral Hemorrhagic Fevers.

Product Overview

This formulation contains Ribavirin, a highly potent, broad-acting antiviral agent that doesn’t just stop viruses from replicating—it forces them to mutate so rapidly and violently that the viral population collapses upon itself.

The “HCV Booster & Viral Hemorrhagic Defense” Specialist:

• Mechanism 1 (Lethal Mutagenesis & Polymerase Inhibition): Once inside an infected cell, Ribavirin is converted into its active triphosphate form. Because it structurally mimics the genetic building block guanosine, the virus mistakenly uses it to build its RNA. This completely jams the viral RNA-dependent RNA polymerase enzyme. Furthermore, it causes the virus to make massive, fatal errors as it tries to copy itself, leading to “error catastrophe” and the total eradication of the virus.
• Mechanism 2 (The Hepatology Rescue Therapy): While modern Direct-Acting Antivirals (DAAs like Sofosbuvir/Velpatasvir) are highly effective, patients with advanced, decompensated liver cirrhosis or those with difficult-to-treat genotypes frequently face treatment failure. Ribavirin is the ultimate “booster” drug. When added to a DAA regimen, it dramatically amplifies the cure rate (SVR12), making it an indispensable asset in global hepatology.
• Mechanism 3 (The Lassa Fever Protocol): Beyond Hepatitis C, Ribavirin is one of the only globally recognized antiviral treatments for severe Viral Hemorrhagic Fevers, specifically Lassa Fever and Crimean-Congo Hemorrhagic Fever. It is procured in massive bulk volumes by the WHO and African health ministries for outbreak containment.

Product Composition & Strength

We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.

*Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Infectious Disease Distributors, and NGO Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Teratogenic High-Containment Engineering: Ribavirin is profoundly teratogenic (causes massive birth defects). Our manufacturing occurs in strict, dedicated isolation blocks operating under severe negative pressure with advanced multi-stage HEPA filtration. This guarantees zero cross-contamination with other drug classes and ensures our facility personnel are completely protected from exposure to the hazardous API dust.

Therapeutic Indications (Human Use)

Indicated for the targeted eradication of severe viral pathogens in combination therapy:

• Chronic Hepatitis C (HCV): Indicated in combination with other Direct-Acting Antivirals (like Sofosbuvir or Velpatasvir) for the treatment of chronic HCV infection in patients with advanced liver disease (decompensated cirrhosis) or treatment-experienced patients. (It is strictly NEVER used as a monotherapy for HCV).
• Viral Hemorrhagic Fevers (Off-Label / NGO Protocol): Treatment and post-exposure prophylaxis for Lassa Fever and other specific RNA viral hemorrhagic fevers.

Dosage & Administration

Recommended Dosage (Strictly as per Hepatologist/Infectious Disease Guidelines):

• Standard Adult Dosing (HCV): Dosing is strictly weight-based. Typically, patients under 75 kg receive 1000 mg daily, and patients over 75 kg receive 1200 mg daily.
• Administration (THE MEALTIME RULE): The total daily dose must be divided (e.g., morning and evening). Tablets MUST be taken with food to maximize absorption and reduce gastrointestinal distress. Tablets must not be crushed or chewed to prevent handler exposure to the teratogenic powder.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• BLACK BOX WARNING (Hemolytic Anemia): The primary and highly dangerous toxicity of Ribavirin is severe hemolytic anemia (the rapid destruction of red blood cells), which can occur within the first 1 to 2 weeks of therapy. This can precipitate fatal myocardial infarctions (heart attacks). Hemoglobin levels must be aggressively monitored, and the dose slashed or discontinued if anemia develops.
• BLACK BOX WARNING (Teratogenicity & Embryocidal Effects): Ribavirin causes massive, fatal birth defects. It is strictly Category X. It must NEVER be used by women who are pregnant or by men whose female partners are pregnant. Extreme caution is required: patients must use two reliable forms of contraception during treatment and for a full 6 months after the last dose, as the drug remains trapped inside red blood cells for months.
• Contraindicated in Severe Renal Impairment: The drug accumulates toxically in patients with failing kidneys. It is contraindicated in patients with creatinine clearance < 50 mL/min unless expertly monitored.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and NGO Health Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antiviral Formulations. Whether you need a reliable NGO Tender Supplier for Lassa fever programs in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery of WHO-GMP certified products.